Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4929097 in Metastatic Colorectal Cancer
NCT01116687Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO4929097 in metastatic colorectal cancer (mCRC), sponsored by National Cancer Institute. Started May 2010; status: completed.
02
Drugs
RO4929097
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01116687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116687.